Cargando…

Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales:	Mozas, Pablo, Rivas-Delgado, Alfredo, Baumann, Tycho, Villamor, Neus, Ortiz-Maldonado, Valentín, Aymerich, Marta, Costa, Dolors, Navarro, Alba, Giné, Eva, López-Guillermo, Armando, Montserrat, Emili, Delgado, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802533/ https://www.ncbi.nlm.nih.gov/pubmed/29339727 http://dx.doi.org/10.1038/s41408-017-0044-5

Ejemplares similares

Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact
por: Mozas, Pablo, et al.
Publicado: (2020)

Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution
por: Rivero, Andrea, et al.
Publicado: (2021)

Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience
por: Mozas, Pablo, et al.
Publicado: (2020)

CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report
por: Baumann, Tycho, et al.
Publicado: (2020)

Clinico‐biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation
por: Bastidas‐Mora, Gabriela, et al.
Publicado: (2021)

Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?
por: Magnano, Laura, et al.
Publicado: (2020)

Detection of chromothripsis‐like patterns with a custom array platform for chronic lymphocytic leukemia
por: Salaverria, Itziar, et al.
Publicado: (2015)

Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
por: Giménez, Neus, et al.
Publicado: (2019)

Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia
por: Giménez, Neus, et al.
Publicado: (2019)

IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
por: Nadeu, Ferran, et al.
Publicado: (2020)

Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma
por: Rivas-Delgado, Alfredo, et al.
Publicado: (2022)

Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter’s Transformation
por: Ortiz-Maldonado, Valentín, et al.
Publicado: (2022)

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
por: Nadeu, Ferran, et al.
Publicado: (2022)

PB2088: IMMUNE PROFILE OF PATIENTS WITH FOLLICULAR LYMPHOMA ASSESSED BY FLOW CYTOMETRY IN PERIPHERAL BLOOD: CHARACTERISTICS AT DIAGNOSIS AND AT RELAPSE OF THE DISEASE
por: Rivero Arango, A., et al.
Publicado: (2022)

Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells
por: López-Guerra, Mónica, et al.
Publicado: (2019)

Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies
por: Delgado, Julio, et al.
Publicado: (2020)

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia
por: Xargay-Torrent, Sílvia, et al.
Publicado: (2015)

Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
por: Delgado, Julio, et al.
Publicado: (2019)

CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia
por: Montraveta, Arnau, et al.
Publicado: (2015)

P1391: VARNIMCABTAGENE AUTOLEUCEL (VAR-CEL) IN RELAPSED/ REFRACTORY CD19+ NON-HODGKIN LYMPHOMA
por: Martinez-Cibrian, Nuria, et al.
Publicado: (2023)

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
por: Nadeu, F, et al.
Publicado: (2018)

Unraveling the genetics of transformed splenic marginal zone lymphoma
por: Grau, Marta, et al.
Publicado: (2023)

Novel Tools for Diagnosis and Monitoring of AML
por: Guijarro, Francesca, et al.
Publicado: (2023)

Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia
por: Gimenez, Neus, et al.
Publicado: (2020)

Practical aspects of chimeric antigen receptor T-cell administration: From commercial to point-of-care manufacturing
por: Martinez-Cibrian, Nuria, et al.
Publicado: (2022)

Factors associated with the clinical outcome of patients with relapsed/refractory CD19(+) acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
por: Ortiz-Maldonado, Valentín, et al.
Publicado: (2021)

The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma
por: Valero, Juan Garcia, et al.
Publicado: (2021)

MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms
por: Fernández-Garnacho, Elena María, et al.
Publicado: (2023)

Patients with relapsed/refractory chronic lymphocytic leukaemia may benefit from inclusion in clinical trials irrespective of the therapy received: a case-control retrospective analsysis
por: Esteban, D, et al.
Publicado: (2015)

Multi-Criteria Evaluation and Sensitivity Analysis for the Optimal Location of Constructed Wetlands (METland) at Oceanic and Mediterranean Areas
por: Peñacoba-Antona, Lorena, et al.
Publicado: (2021)

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions
por: Puiggros, Anna, et al.
Publicado: (2017)

All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia
por: López-Oreja, Irene, et al.
Publicado: (2023)

Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review
por: Rivero, Andrea, et al.
Publicado: (2023)

Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial
por: Castella, Maria, et al.
Publicado: (2020)

Ventilator-associated pneumonia diagnosis: a prioritization exercise based on multi-criteria decision analysis
por: Ferreira-Coimbra, João, et al.
Publicado: (2019)

Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study
por: Moreno, Carol, et al.
Publicado: (2018)

Practical Aspects of Allogeneic Hematopoietic Cell Transplantation for Patients with Poor-Risk Chronic Lymphocytic Leukemia
por: Delgado, Julio, et al.
Publicado: (2011)

Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients
por: Delgado-Ureña, Mayte, et al.
Publicado: (2018)

Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
por: Ferreira, Pedro G., et al.
Publicado: (2014)

CRITERIA OF THE AGE OF LYMPHOCYTES IN THE PERIPHERAL BLOOD
por: Wiseman, Bruce K.
Publicado: (1931)

Cannot write session to /tmp/vufind_sessions/sess_un0ckt07nlu1l7c1nitclrrdfb